Signal Transduction and Targeted Therapy | Molecular Pathogenesis of Osteoarthritis and Potential Therapeutic Strategies

This review systematically elucidates the interplay among inflammatory cytokines, organelle dysfunction, and pain pathways in osteoarthritis, and proposes a novel multimodal therapeutic paradigm targeting organelle homeostasis and inflammatory signaling, providing a theoretical foundation for disease-modifying therapies.

 

Literature Overview

The article 'Osteoarthritis: molecular pathogenesis and potential therapeutic options,' published in Signal Transduction and Targeted Therapy, reviews and summarizes the molecular pathogenesis of osteoarthritis (OA), with a focus on the interactions between inflammatory cytokines (e.g., IL-1β, TNF-α, IL-6), chondrocyte organelle dysfunction (mitochondria, lysosomes, endoplasmic reticulum), and pain signaling pathways. The article further analyzes OA-related structural changes and pain mechanisms, and systematically outlines emerging pharmacological strategies targeting inflammatory cascades, restoring organelle homeostasis, and inhibiting nociceptive signaling. Additionally, it introduces advanced organelle-targeted drug delivery systems designed to enhance therapeutic efficacy and drug stability. The entire section is coherent and logically structured, ending with a Chinese period.

Background Knowledge

Osteoarthritis is a chronic joint disorder characterized by cartilage degeneration, subchondral bone remodeling, and synovial inflammation, and is one of the leading causes of chronic pain and functional disability worldwide. Despite its rising prevalence, particularly among the elderly and obese populations, current treatments remain largely symptomatic, lacking effective means to halt or reverse disease progression. Recent research has revealed that OA is not simply a 'wear-and-tear' condition, but rather a complex metabolic joint disorder involving multiple cell types and molecular pathways. Pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6 play central roles in driving cartilage degradation and promoting the expression of matrix metalloproteinases (MMPs) and ADAMTS family proteases. Moreover, organelle dysfunction within chondrocytes—including oxidative stress due to mitochondrial dysfunction, apoptosis triggered by lysosomal membrane permeabilization, and unresolved endoplasmic reticulum stress—has been established as a key mechanism in OA progression. In addition, pain, the primary reason patients seek medical care, involves peripheral and central sensitization, yet current analgesic treatments offer limited efficacy. Therefore, combined intervention strategies targeting the inflammation-organelle axis and pain pathways represent a cutting-edge direction in OA therapeutic research. This study systematically integrates recent advances in OA pathogenesis and proposes a multi-target synergistic treatment framework with significant theoretical and translational value.

 

 

Research Methods and Experiments

This article is a review based on a systematic summary and integrative analysis of a large body of primary research literature in the field of osteoarthritis over recent years. The authors elaborate on multiple dimensions including epidemiology, prevention, diagnosis, pathogenesis, and therapeutic strategies. At the mechanistic level, the focus is on the signaling pathways of pro-inflammatory cytokines (IL-1, TNF-α, IL-6) and their impact on cartilage matrix degradation, chondrocyte apoptosis, and bone remodeling. The article also deeply explores the roles of mitochondrial dysfunction (e.g., imbalanced mitophagy mediated by PINK1/Parkin), lysosomal instability (e.g., LMP caused by hydroxyapatite accumulation), and endoplasmic reticulum stress in OA. Additionally, it reviews recent advances in joint-central nervous system pain pathways and evaluates the limitations of current pharmacological and surgical interventions.

Key Conclusions and Perspectives

• The pathogenesis of osteoarthritis involves a vicious cycle between pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) and chondrocyte organelle dysfunction (mitochondria, lysosomes, endoplasmic reticulum), collectively driving cartilage degradation and cell apoptosis
• Mitochondrial dysfunction manifests as excessive ROS production, impaired ATP synthesis, and imbalanced mitophagy, with dysregulation of the PINK1/Parkin pathway as a key node
• Lysosomal dysfunction due to hydroxyapatite deposition leads to loss of acidification capacity, resulting in membrane permeabilization, release of cathepsins B/D, activation of the BID-BAX pathway, and ultimately chondrocyte apoptosis
• Unresolved endoplasmic reticulum stress continuously activates the unfolded protein response (UPR), promoting inflammatory cytokine release and matrix degradation, thereby exacerbating OA progression
• IL-6 exerts dual effects through classical and trans-signaling pathways, and its imbalance is closely associated with inflammation and metabolic dysregulation in OA
• Combined therapeutic strategies targeting organelle homeostasis (e.g., enhancing mitophagy, preserving lysosomal integrity, alleviating ER stress) and inhibiting inflammatory signaling pathways hold promise for disease modification
• Advanced organelle-targeted drug delivery systems can improve drug accumulation and stability in cartilage tissue, enhancing therapeutic efficacy

Research Significance and Prospects

This study systematically integrates recent advances in the molecular mechanisms of OA and proposes a 'inflammation-organelle-pain' ternary network model, offering a new perspective for understanding the complex pathology of OA. The proposed multimodal therapeutic paradigm transcends the limitations of traditional single-target strategies by emphasizing synergistic intervention at multiple key nodes, demonstrating significant translational potential.

Future research should further explore inter-organelle communication (e.g., mitochondria-lysosome axis, ER-mitochondria contact sites) in OA and develop more efficient organelle-targeted nanocarriers. Furthermore, integrating dynamic biomarker monitoring with personalized treatment strategies may enable precision intervention in OA. This review lays a solid theoretical foundation for developing truly disease-modifying OA therapies.

 

 

Conclusion

Osteoarthritis is a highly complex degenerative joint disease whose pathogenesis extends far beyond the traditional 'mechanical wear' model, involving extensive interactions among inflammatory signaling, organelle dysfunction, and neural pain pathways. This article systematically summarizes the central roles of pro-inflammatory cytokines IL-1β, TNF-α, and IL-6 in driving cartilage matrix degradation and amplifying inflammation, and deeply analyzes how mitochondrial dysfunction, lysosomal membrane permeabilization, and endoplasmic reticulum stress synergistically promote chondrocyte apoptosis and tissue degeneration. Notably, the article emphasizes the pivotal role of disrupted organelle homeostasis in OA progression and proposes that drug delivery systems targeting these organelles can enhance treatment specificity and efficacy. Based on these insights, the authors advocate a novel therapeutic paradigm of multi-target synergistic intervention, aiming to simultaneously suppress inflammation, restore organelle function, and alleviate pain, thereby achieving dual protection of joint structure and function. This integrated perspective provides a solid theoretical basis for developing therapies that truly alter the disease course of osteoarthritis, representing a significant shift from symptom management toward mechanism-based intervention.

 

Yi Zhang, Yanqi Han, Ying Sun, Yuling Liu, and Yanfang Yang. Osteoarthritis: molecular pathogenesis and potential therapeutic options. Signal Transduction and Targeted Therapy.